BBlogFlow

European Commission expands list of well-established technologies under MDR - RAPS

·Jun 30, 2026

This story deserves to be shared

Send it to someone who'd care, or post it on your networks.

Facebook Twitter Email

This article is an excerpt. To read the full content, visit the original source. RAPS

Reactions

0 comments

No comments yet. Be the first to share your thoughts!

Facebook Twitter

Related articles

Baseline radiographic and microbiologic predictors of treatment outcomes in a shortened all-oral regimen for MDR/RR-TB - Nature

AcknowledgementsThe authors are indebted to the patients who participated in the STEM-TB observational study and to the clinicians and program staff members of participating health facilities. We also acknowledge and thank the STEM-TB data team, including Joalane Makaka, Mahooe Thoakana, Refiloe Maime, Tlotlisang Thai, Litsoanelo Musa, and Daniel Monyaesa. FundingThis work was supported by the Global Fund to Fight AIDS, Tuberculosis, and Malaria and by the National Institute of Allergy and Infectious Diseases (grant number R01AI146095; to S. M., L. M., M. T., S. P., A. L., L. T., M. R., E. O., M. L. R., C. D. M., K. J. S., M. F. F., and K. K. M.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. Author informationAuthor notesThese authors contributed equally: Molly F. Franke, Kunda Kwabisha Mikanda. Authors and AffiliationsHarvard Medical School, Boston, Massachusetts, USAEdmund Q. L. ShenDepartment of Medicine, University of California, San Francisco, CA, San Francisco, USAEdmund Q. L.

Nature·